Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Kidney International|March 19, 2017
A proposal for standardized grading of chronic changes in native kidney biopsy specimensSanjeev Sethi, Vivette D D'Agati, Cynthia C Nast, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2020
Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case SeriesIbrahim Batal, Elena-Rodica Vasilescu, Darshana M Dadhania, et al.
Annals of Internal Medicine|December 6, 2017
Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot StudySneh Lata, Maddalena Marasa, Yifu Li, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Lancet (London, England)|November 6, 2023
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, et al.
Kidney International|September 24, 2021
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular DiseasesBrad H Rovin, Sharon G Adler, Jonathan Barratt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder WorkshopsSimon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International|May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular diseaseSimon A Carter, Charlotte Logeman, Martin Howell, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Pageof 19